Anti-EMIL1/ EMILIN1/ EMI functional antibody

Anti-EMIL1/ EMILIN1/ EMI functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to EMILIN1/EMILIN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0175-Ab-1/ GM-Tg-hg-SE0175-Ab-2Anti-Human EMILIN1 monoclonal antibodyHuman
GM-Tg-rg-SE0175-Ab-1/ GM-Tg-rg-SE0175-Ab-2Anti-Rat EMILIN1 monoclonal antibodyRat
GM-Tg-mg-SE0175-Ab-1/ GM-Tg-mg-SE0175-Ab-2Anti-Mouse EMILIN1 monoclonal antibodyMouse
GM-Tg-cynog-SE0175-Ab-1/ GM-Tg-cynog-SE0175-Ab-2Anti-Cynomolgus/ Rhesus macaque EMILIN1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0175-Ab-1/ GM-Tg-felg-SE0175-Ab-2Anti-Feline EMILIN1 monoclonal antibodyFeline
GM-Tg-cang-SE0175-Ab-1/ GM-Tg-cang-SE0175-Ab-2Anti-Canine EMILIN1 monoclonal antibodyCanine
GM-Tg-bovg-SE0175-Ab-1/ GM-Tg-bovg-SE0175-Ab-2Anti-Bovine EMILIN1 monoclonal antibodyBovine
GM-Tg-equg-SE0175-Ab-1/ GM-Tg-equg-SE0175-Ab-2Anti-Equine EMILIN1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0175-Ab-1/ GM-Tg-hg-SE0175-Ab-2; GM-Tg-rg-SE0175-Ab-1/ GM-Tg-rg-SE0175-Ab-2;
GM-Tg-mg-SE0175-Ab-1/ GM-Tg-mg-SE0175-Ab-2; GM-Tg-cynog-SE0175-Ab-1/ GM-Tg-cynog-SE0175-Ab-2;
GM-Tg-felg-SE0175-Ab-1/ GM-Tg-felg-SE0175-Ab-2; GM-Tg-cang-SE0175-Ab-1/ GM-Tg-cang-SE0175-Ab-2;
GM-Tg-bovg-SE0175-Ab-1/ GM-Tg-bovg-SE0175-Ab-2; GM-Tg-equg-SE0175-Ab-1/ GM-Tg-equg-SE0175-Ab-2
Products NameAnti-EMILIN1 monoclonal antibody
Formatmab
Target NameEMILIN1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EMILIN1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0175-Ag-1Recombinant multi-species EMIL1/ EMILIN1/ EMI protein


    Target information

    Target IDGM-SE0175
    Target NameEMILIN1
    Gene ID11117,100952,298845,698204,475696,101081035,540451,100055491
    Gene Symbol and Synonyms5830419M17Rik,EMI,EMILIN,EMILIN-1,EMILIN1,gp115,HMN10
    Uniprot AccessionQ9Y6C2
    Uniprot Entry NameEMIL1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000138080
    Target ClassificationN/A

    The target: EMILIN1, gene name: EMILIN1, also named as EMI, EMILIN, gp115. This gene encodes an extracellular matrix glycoprotein that is characterized by an N-terminal microfibril interface domain, a coiled-coiled alpha-helical domain, a collagenous domain and a C-terminal globular C1q domain. The encoded protein associates with elastic fibers at the interface between elastin and microfibrils and may play a role in the development of elastic tissues including large blood vessels, dermis, heart and lung. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.